semaglutide prediabetes progression to diabetes step trial 2·4 mg once a week in adults with overweight or obesity, and type 2 (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 TrimRX | How to Track

Comparing GLP-1 Medications: Key Differences and Considerations Choosing among the various GLP 1 options requires understanding key differences in dosing frequency, efficacy and practical considerations around cost and access

Our Toll-free number is 1-800-226-3784 (1-800-CAN-DRUG)

Chronic inflammation, a recognized catalyst in oncogenesis, is mitigated by GLP-1s capacity to downregulate pro-inflammatory cytokine production and improve insulin sensitivity

2 The half-life of semaglutide after subcutaneous administration is up to 183 h

Your provider may recommend blood pressure control first, then introduce GLP-1 as an additional metabolic benefit with careful monitoring

Both injected and oral semaglutide carry similar bloating risk during the dose titration phase, though some patients report slightly faster adaptation with injections due to more consistent bioavailability